MAPT and Alzheimer disease: The progression from MCI to AD is thought to be precipitated by the accumulation of the cerebrospinal fluid (CSF) biomarkers such as Amyloid-β plaques, P-tau181, and T-tau tangles within the brain, which are key indicators of AD’s pathology [4,14].